FDA plans to ease rules for reprinting off-label use info
March 10th, 2008 Posted by: Dr. Dobson
Washington — Drug firms would have a more direct route to physicians when it comes to spreading the word about new research findings for off-label uses of drugs and devices, if a new Food and Drug Administration proposal is finalized.
The proposal, which was published in the Feb. 20 Federal Register, would allow pharmaceutical manufacturers to distribute reprints of journal articles that support a particular use of a drug or device that does not appear on its label.
Popularity: unranked [?]
Tags: plans, rules, reprinting, off-label